Stock screenerAll disclosures →
EDGAR →
ALEC
Conviction 34HealthcareScan · Thu, Jun 25, 2026ALEC$1.85+3.07%
ResistanceSupportVol 14Insider sell3
Vol MA14 763.48K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price1.85
Change+3.07%
Gap-0.56%
Rel volume2.80×
Avg volume869.52K
Avg $ vol1.57M
SMA 201.75
SMA 502.10
SMA 2002.05
Price vs 50-12.24%
Price vs 200-10.13%
MA stackmixed
50/200 cross—
Supertrenddown · 1.95
RSI (14)50
MACD hist0.04
MACD crossbull · 3d
Stoch %K / %D73 / 75
ADX (14)31
+DI / −DI24 / 21
RSI divergence—
MACD divergence—
ATR %+8.78%
ADR %9.04%
52w high3.32
52w low1.14
From 52w high-44.43%
Above 52w low+61.84%
New 52w highNo
SqueezeOff
Bollinger width46.24%
%B0.62
Donchian pos51.79%
Donchian high2.25
Donchian low1.41
AVWAP (52w high)1.74
vs AVWAP high+6.09%
AVWAP (52w low)1.88
vs AVWAP low-1.80%
OBV trendFlat
Chaikin MF (20)-0.22
Today vs 20d2.80×
Avg vol (14d)763.48K
Avg vol (20d)869.52K
Avg $ vol (20d)1.57M
Market cap204.84M
RS 3m (vs SPY)-26.20%
RS 6m (vs SPY)+20.12%
RS line new highNo
Trend template1/8
Technical rank43.4
1 week+18.27%
1 month-15.75%
3 months-14.98%
6 months+27.24%
1 year+23.83%
YTD+20.59%
P/E-1.43
P/B19.73
P/S9.73
P/FCF-1.11
EPS-1.39
Div yield—
ROE—
ROA-59.57%
Debt/Eq0.94
Current5.25
EV/EBITDA-0.92
Gross margin—
Net margin-679.16%
Rev growth-79.07%
EPS growth-20.06%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value137.65M
Revenue1.05M
Net income-22.93M
Gross profit—
Free cash flow-184.07M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out111.03M
Employees103
ListedThu, Feb 7, 2019
Free float82.98M
Float %76.0%
Short interest5.09M
Days to cover6.6d
Short volume6.4%
Squeeze score52 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.24 · 4 est
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction34 / 100
Pattern quality—
Tech rank43.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance2.54
Support1.45
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ALEC
No recent disclosed trades by Congress in ALEC. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ALEC · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
SCHELLER RICHARD H Director · Stock Option (right to buy) · 2026-06-17 | Grant | 9.45K | — | 2026-06-17 | 2026-06-17 |
GAROFALO ELIZABETH A. Director · Stock Option (right to buy) · 2026-06-17 | Grant | 9.45K | — | 2026-06-17 | 2026-06-17 |
Yaffe Kristine Director · Stock Option (right to buy) · 2026-06-17 | Grant | 9.45K | — | 2026-06-17 | 2026-06-17 |
LAVIGNE LOUIS J JR Director · Common Stock · 2026-06-17 | Grant | 28.7K | — | 2026-06-17 | 2026-06-17 |
LAVIGNE LOUIS J JR Director · Stock Option (right to buy) · 2026-06-17 | Grant | 9.45K | — | 2026-06-17 | 2026-06-17 |
DESOUZA ERROL B Director · Common Stock · 2026-06-17 | Grant | 28.7K | — | 2026-06-17 | 2026-06-17 |
DESOUZA ERROL B Director · Stock Option (right to buy) · 2026-06-17 | Grant | 9.45K | — | 2026-06-17 | 2026-06-17 |
Altmeyer Mark Director · Common Stock · 2026-06-17 | Grant | 28.7K | — | 2026-06-17 | 2026-06-17 |
Altmeyer Mark Director · Stock Option (right to buy) · 2026-06-17 | Grant | 9.45K | — | 2026-06-17 | 2026-06-17 |
SCHELLER RICHARD H Director · Common Stock · 2026-06-17 | Grant | 28.7K | — | 2026-06-17 | 2026-06-17 |
SEC filings
EDGAR filings in ALEC · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.